US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
NKGen Biotech Inc (NKGN)
NKGen Biotech Inc (NKGN) ニュース

NKGN

NKGen Biotech (NKGN)

NKGen Biotech Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NKGN

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/02/23	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2024/02/15	10 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NKGN	NKGen Biotech Inc
2024/02/15	10 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NKGN	NKGen Biotech Inc
2024/02/15	10 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NKGN	NKGen Biotech Inc
2024/02/15	10 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NKGN	NKGen Biotech Inc
2024/02/15	03 : 05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NKGN	NKGen Biotech Inc
2024/01/22	20 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2024/01/09	07 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2023/12/29	06 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2023/12/28	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2023/12/28	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2023/12/20	03 : 41	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NKGN	NKGen Biotech Inc
2023/11/15	06 : 39	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NKGN	NKGen Biotech Inc
2023/10/24	23 : 56	Dow Jones News	NKGen Biotech Shares Rise 8% After FDA Clears IND Application for SNK01	NASDAQ:NKGN	NKGen Biotech Inc
2023/10/24	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc

Showing the most relevant articles for your search:NASDAQ:NKGN

1

Esm Tf 0,01% Ot31 Eur

Euronext France 40 Respo...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約